Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
ANI Arizona Neurological Institute Research, PC
mi
from
Sun City, AZ
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
ANI Arizona Neurological Institute Research, PC
mi
from
Sun City, AZ
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Banner Sun Health Research Institute
mi
from
Sun City, AZ
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Banner Sun Health Research Institute
mi
from
Sun City, AZ
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Center for Neurosciences
mi
from
Tucson, AZ
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Center for Neurosciences
mi
from
Tucson, AZ
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
American Neuropsychiatric Research Institute, Inc
mi
from
Carson, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
American Neuropsychiatric Research Institute, Inc
mi
from
Carson, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Neurology Center of North Orange County
mi
from
Fullerton, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Neurology Center of North Orange County
mi
from
Fullerton, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Institute for Memory Impairment & Neurological Disorders
mi
from
Irvine, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Institute for Memory Impairment & Neurological Disorders
mi
from
Irvine, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
The University of California, San Diego
mi
from
La Jolla, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Senior Clinical Trials, Inc.
mi
from
Laguna Hills, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Senior Clinical Trials, Inc.
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Torrance Clinical Research
mi
from
Lomita, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Torrance Clinical Research
mi
from
Lomita, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Apostle Clinical Trials, Inc
mi
from
Long Beach, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Apostle Clinical Trials, Inc
mi
from
Long Beach, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Collaborative Neuroscience Network - CNS
mi
from
Long Beach, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Collaborative Neuroscience Network - CNS
mi
from
Long Beach, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
UCLA Medical Center
mi
from
Los Angeles, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
University of Southern California Medical Center
mi
from
Los Angeles, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
University of Southern California Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
University of California, Los Angeles, School of Medicine
mi
from
Los Angeles, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
University of California, Los Angeles, School of Medicine
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Hoag Memorial Hospital
mi
from
Newport Beach, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Hoag Memorial Hospital
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Pacific Neuroscience Medical Group
mi
from
Oxnard, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Pacific Neuroscience Medical Group
mi
from
Oxnard, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Anderson Clinical Research
mi
from
Redlands, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Anderson Clinical Research
mi
from
Redlands, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
University of California, Davis - Health Systems
mi
from
Sacramento, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
University of California, Davis - Health Systems
mi
from
Sacramento, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Pacific Research Network
mi
from
San Diego, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Pacific Research Network
mi
from
San Diego, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Sharp Mesa Vista Hospital
mi
from
San Diego, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Sharp Mesa Vista Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
San Francisco Clinical Research Center
mi
from
San Francisco, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
San Francisco Clinical Research Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Apex Research Institute
mi
from
Santa Ana, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Apex Research Institute
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
St. Joseph Health
mi
from
Santa Rosa, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
St. Joseph Health
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
California Neuroscience Research
mi
from
Sherman Oaks, CA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
California Neuroscience Research
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Radiant Research, Inc.
mi
from
Denver, CO
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Radiant Research, Inc.
mi
from
Denver, CO
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Associated Neurologists of Southern Connecticut, PC
mi
from
Fairfield, CT
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Associated Neurologists of Southern Connecticut, PC
mi
from
Fairfield, CT
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Yale University School of Medicine
mi
from
New Haven, CT
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Research Center for Clinical Studies, Inc.
mi
from
Norwalk, CT
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Research Center for Clinical Studies, Inc.
mi
from
Norwalk, CT
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Christiana Care Research Institute
mi
from
Newark, DE
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Christiana Care Research Institute
mi
from
Newark, DE
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Georgetown University Hospital
mi
from
Washington,
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Georgetown University Hospital
mi
from
Washington,
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Parkinson's Disease and Movement Disorders
mi
from
Boca Raton, FL
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Parkinson's Disease and Movement Disorders
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Quantum Laboratories
mi
from
Deerfield Beach, FL
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Quantum Laboratories
mi
from
Deerfield Beach, FL
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Cohen Medical Associates
mi
from
Delray Beach, FL
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Cohen Medical Associates
mi
from
Delray Beach, FL
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Neuropsychiatric Research Center of Southwest Florida
mi
from
Fort Myers, FL
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Neuropsychiatric Research Center of Southwest Florida
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
MD Clinical
mi
from
Hallandale Beach, FL
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
MD Clinical
mi
from
Hallandale Beach, FL
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Galiz Research
mi
from
Hialeah, FL
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Galiz Research
mi
from
Hialeah, FL
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Infinity Clinical Research, LLC
mi
from
Hollywood, FL
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Infinity Clinical Research, LLC
mi
from
Hollywood, FL
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Miami Jewish Home and Hospital for the Aged
mi
from
Miami, FL
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Miami Jewish Home and Hospital for the Aged
mi
from
Miami, FL
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Renstar Medical Research
mi
from
Ocala, FL
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Renstar Medical Research
mi
from
Ocala, FL
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Compass Research LLC
mi
from
Orlando, FL
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Neurology Clinical Research Inc.
mi
from
Sunrise, FL
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Neurology Clinical Research Inc.
mi
from
Sunrise, FL
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Axiom Research
mi
from
Tampa, FL
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Axiom Research
mi
from
Tampa, FL
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Stedman Clinical Trials
mi
from
Tampa, FL
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Stedman Clinical Trials
mi
from
Tampa, FL
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
University of South Florida
mi
from
Tampa, FL
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Premiere Research Institute at Palm Beach Neurology
mi
from
West Palm Beach, FL
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Premiere Research Institute at Palm Beach Neurology
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Rush Alzheimer's Disease Center
mi
from
Chicago, IL
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Rush Alzheimer's Disease Center
mi
from
Chicago, IL
Click here to add this to my saved trials